Amyloidosis is classically divided into 2 groups: the primary form, which is usually associated with a plasma cell dyscrasia and characterised by amyloid L protein (AL), and the secondary form, which is associated with chronic infections or inflammatory processes and characterised by amyloid A protein (AA).1 Some forms of chronic arthritis are characterised by a prolonged and intense inflammatory response which may predispose to the appearance of amyloidosis. In fact amyloidosis is a major complication of rheumatoid arthritis, juvenile rheumatoid arthritis, and ankylosing spondylitis and may be associated with psoriatic arthritis and systemic lupus erythematosus.28
The present report describes 2 patients with gout and amyloidosis and a search of the literature revealed only 5 14 . At first the disease affected the metatarsal joints, the ankles, and the knees. Later it progressed to the metacarpal joints and the elbows. In the course of time the joints became extremely deformed, and multiple nodules, histologically diagnosed as tophi, appeared, mainly on the extensor surfaces of the extremities. Some of the tophi had secreting sinuses with longstanding secondary bacterial infection. The diagnosis of gouty arthritis was established by the demonstration of urate crystals in the nodules, serum uric acid levels of 580 ,umol/l, and uricosuria of up to 5350 ,umol/24 hours on a low-purine diet.
The patient never adhered to any therapeutic regimen except for colchicine during acute attacks. At the age of 29 he was noted to have polyuria, the concentrating capacity of the kidney was decreased, blood urea rose to 11 mmol/l, creatinine to 230 p.mol/l, and creatinine clearance was 36 ml/min.
Urine analysis showed traces of protein and a few erythrocytes, leucocytes, and granular casts per highpower field. Kidney biopsy showed uric acid granulomas in the medulla and no changes in the glomeruli. Renal function remained satisfactory during the following 10 years. However, a gradual deterioration started at the age of 39, and the patient died of severe renal failure and terminal bronchopneumonia at the age of 46. Necropsy showed bronchopneumonia and amyloidosis of the kidneys, adrenals, and testicular blood vessels as evidenced by positive Congo-red staining and green birefringence. The kidneys were contracted because of amyloidosis, and uric acid crystals were found in the tubuli.
Case 2. A 39-year-old Jewish male was first admitted to hospital in the Department of Medicine because of a typical attack of gout affecting the first metatarsophalangeal joint of the right foot. The patient had a 3-month history of arthralgia affecting the knees and ankles. The family history was not significant. The patient was known to have a high erythrocyte sedimentation rate and massive proteinuria, which were detected in the course of a routine examination a year before admission. 589 Gout has been estimated to affect at least 300 000 people in the United States." In view of this high incidence and the small number of patients with amyloidosis reported so far it seems that gouty arthritis is not associated with an increased incidence of amyloidosis. In fact 2 of the 4 patients described by Talbott (nos. 2 Gout and amyloidosis 591 localised and limited. However, other localised infections and inflammatory processes, for example, osteomyelitis and Crohn's disease, are nevertheless known to trigger amyloidosis. Another possibility is that the inflammatory process in gout differs in nature from that in rheumatoid arthritis. Perhaps the inflammation and macrophage and polymorphonuclear activation induced by uric acid is specifically devoid of amyloidogenic properties. This hypothesis can be explored in gouty patients and in animal experiments. In patients one could monitor the serum amyloid precursor (SAA) level in correlation to disease activity. A positive correlation has already been detected in patients with rheumatoid arthritis. In animals one could follow SAA levels and amyloid deposition following chronic intra-articular administration of monosodium urate crystals. Another factor which might possibly explain the low incidence ofamyloidosis in gout is the administration of colchicine. This agent has been shown to prevent casein-induced amyloidosis in mice.1213 Furthermore, a few patients with familial Mediterranean fever complicated by amyloidosis have shown regression of albuminuria during continuous, prolonged treatment with colchicine.14 However, since the large majority of patients with gout are treated with colchicine only during attacks and many patients take no colchicine at all, it is unlikely that the low incidence of amyloidosis in this disease is related to this drug.
In conclusion, it seems that gouty arthritis, in contrast to other forms of chronic arthritis, is not significantly associated with amyloidosis. The reasons for this exception are not clear, and further investigation is needed to unveil the mechanisms involved. A deeper insight into this problem may possibly elucidate some of the pathogenic processes involved in secondary amyloidosis.
